Clinical Edge Journal Scan

Elevated odds of motor vehicle crashes in older adults after newly diagnosed migraine


 

Key clinical point: The likelihood of motor vehicle crashes (MVC) in the year following diagnosis is significantly higher among older drivers who have recently been diagnosed with migraine, emphasizing the necessity for driving safety interventions for these individuals.

Major finding: The risk for an MVC in the year after migraine onset was > 3 times higher among older adult drivers with new-onset migraine compared with those who never had a migraine (adjusted odds ratio [aOR] 3.27; P = .019). Prevalent migraine was not associated with MVC in the subsequent 2 years (aOR 0.97; P = .88).

Study details: Findings are from the AAA Longitudinal Research on Aging Drivers study, which included 2589 older drivers (age 65-79 years) with a valid driver’s license, of whom 12.5% and 1.3% reported prevalent and incident migraines, respectively.

Disclosures: This study was funded by the AAA Foundation for Traffic Safety and National Center for Advancing Translational Sciences. The authors declared no conflicts of interest.

Source: DiGuiseppi CG et al. Migraine headaches are associated with motor vehicle crashes and driving habits among older drivers: Prospective cohort study. J Am Geriatr Soc. 2023 (Dec 22). doi: 10.1111/jgs.18719

Recommended Reading

Galcanezumab effective for migraine prevention in women with menstrually related migraine
Migraine ICYMI
Prior onabotulinumtoxin-A improves subsequent anti-CGRP mAb response in chronic migraine
Migraine ICYMI
Comparative efficacy of anti-CGRP mAb in chronic and high-frequency episodic migraine
Migraine ICYMI
Galcanezumab and rimegepant offer effective options for prevention of episodic migraine
Migraine ICYMI
Galcanezumab and rimegepant offer effective options for prevention of episodic migraine
Migraine ICYMI
Fremanezumab benefits migraine patients with inadequate response to prior preventive medications
Migraine ICYMI
Commentary: Examining CGRP Antagonists for Migraine Relief, January 2024
Migraine ICYMI
Building a Toolkit for the Treatment of Acute Migraine
Migraine ICYMI
Retinal Perfusion Is Reduced During Migraine Attacks
Migraine ICYMI
Dispelling Common Headache Myths
Migraine ICYMI